Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...
CRISPR gene therapy increases haemoglobin and fetal haemoglobin in sickle cell disease, reducing vaso occlusive events in ...
Learn about the groundbreaking gene therapy for sickle cell disease at Manning Family Children's Hospital in Louisiana, ...
A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with ...
Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
For the first time in Germany, a long-term, sustainable access agreement to a gene therapy has been established for people living with sickle cell disease and transfusion-dependent beta thalassemia,” ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in ...
A $2.5 million gift by Ted W. Love and Joyce Y. Love to UCSF Benioff Children’s Hospitals will expand care for patients with ...
Serenity Cole lives in St. Louis with her grandmother, Theresa Cole. Serenity is doing well after being one of the first patients to get a gene therapy treatment for sickle cell disease under a new ...
About 10% of people hospitalized with sickle cell on Long Island between 2009 and 2022 faced a "major risk of mortality," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results